Filter News
Area of Research
- (-) Biology and Environment (6)
- Advanced Manufacturing (3)
- Clean Energy (18)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Fusion and Fission (6)
- Fusion Energy (1)
- Isotopes (4)
- Materials (7)
- Materials for Computing (10)
- Neutron Science (15)
- Nuclear Science and Technology (1)
- Sensors and Controls (1)
- Supercomputing (4)
News Topics
- (-) Biomedical (4)
- (-) Exascale Computing (1)
- (-) Materials Science (1)
- (-) Neutron Science (1)
- 3-D Printing/Advanced Manufacturing (2)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (10)
- Biology (18)
- Biotechnology (4)
- Chemical Sciences (1)
- Clean Water (5)
- Climate Change (5)
- Composites (1)
- Computer Science (3)
- Decarbonization (1)
- Energy Storage (1)
- Environment (24)
- Fusion (1)
- High-Performance Computing (5)
- Materials (3)
- Mercury (3)
- Microscopy (1)
- Nanotechnology (1)
- Polymers (1)
- Security (1)
- Summit (2)
- Sustainable Energy (8)
Media Contacts
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
As rising global temperatures alter ecosystems worldwide, the need to accurately simulate complex environmental processes under evolving conditions is more urgent than ever.
The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.